Abstract-Hyperglycaemia in critically ill patients increases the risk of further complications and mortality. A long-term verification of a model that captures the essential glucose-and insulin-kinetics is presented, using retrospective data gathered in an Intensive Care Unit (ICU). The model uses only two patient specific parameters, for glucose clearance and insulin sensitivity. The optimization of these parameters is accomplished through a novel integration-based fitting approach, and a piecewise linearization of the parameters. This approach reduces the non-linear, non-convex optimization problem to a simple linear equation system. The method was tested on long-term blood glucose recordings from 17 ICUpatients, resulting in an average error of 7%, which is in the range of the sensor error. One-hour predictions of blood glucose data proved acceptable with an error range between 7-11%. These results verify the model's ability to capture longterm observed glucose-insulin dynamics in hyperglycaemic ICU patients.
I. INTRODUCTION
Critically ill patients often experience stress-induced hyperglycemia and high levels of insulin resistance, even if they have no history of diabetes [1] [2] [3] . Hyperglycemia can lead to an increased risk of further complications such as severe infections, myocardial infarctions, polyneuropathy and multiple organ failure [1, 4, 5] . Tight glucose control has been shown to reduce intensive care unit (ICU) patient mortality by as much as 45% [1] . To automate blood glucose management, models of insulin-and glucosekinetics are required that are capable of capturing long-term dynamics in a physiological realistic way. A new, physiologically verified model [6] and novel integrationbased fitting method are presented to evaluate the validity of the model over long periods using retrospective clinical data.
II. METHODOLOGY

A. Model
The basis for the presented model is the 3-compartment Minimal Model proposed by Bergman [7] . It was reduced to 2 compartments [8] and enhanced by additional dynamics [6, 9] . These additional dynamics account for an accumulation dynamic of insulin [10, 11] , non-linear saturation of exogenous insulin appearance [12] , and saturation of insulin utilisation and glucose clearance [13, 14] . To reduce model complexity and better match known physiological response, a term was included to suppress endogenous insulin secretion during periods of high exogenous insulin infusion [15] . The resulting model is defined:
( ) 
where G = concentration of the plasma glucose above the basal level (mmol/L), G E = equilibrium level for plasma glucose concentration (mmol/L), I = concentration of the plasma insulin above basal level (mU/L), I B = basal level for plasma insulin concentration (mU/L), P(t) = exogenous glucose infusion rate (mmol/(L·min)), u(t) = insulin infusion rate (mU/min), V I = assumed insulin distribution volume (L), n = delay in interstitial transfer of insulin (min -1 ), p G = fractional clearance of plasma glucose at basal insulin(min This model has been physiologically verified over short 5 hour clinical trials for adaptive, targeted glucose control [6, 9] .
B. Parameter Fitting and Identification
The objectives for the fitting method are low computation time, high accuracy for tracking changes in time varying patient specific parameters (p G , S I ) and physiologically realistic values of optimised parameters. A method that is convex and not dependent on starting points, as with non-linear recursive least squares (NRLS) [16] , is also desirable.
Generic parameters (V I = 12 L, n = 0.16 min -1 , k = 0.0099 min -1 , G = 0.04 L/mU, I = 0.0017 L/mU) were found through extensive literature research [6] and are assumed to be constant. The exogenous feed details, P(t), are known for each patient. The equilibrium glucose level, G E , can be estimated by averaging the glucose readings across the prior 12 hours.
To identify p G and S I , the L 2 norm between the measured data and the model output is minimized. Integration of (3) and substitution of the total measured glucose level G T =(G+G E ) and insulin saturation term ) 1 (
delivers the following expression:
To reduce computational complexity and account for a variation over time, the total time interval is divided into equal segments during which p G and S I are held constant, and are defined using heavyside step functions, H(t).
The only unknown parameters in (4), p Gi and S Ii , are now constant over these time intervals and can be written in a simple linear equation system. The number of equations for each time segment can be arbitrarily selected:
To make sure both p G and S I are within physiologically valid ranges, weighted constraints are placed on both parameters when solving (7) .
To best compute the integrals in (4), the profile of G T is approximated using simple linear interpolation between the data points, forming a piecewise linear curve G T-approx . The error between the patient's real glucose level G T-real and the approximated curve G T-approx is ε:
Using (4) 
Where the error term E(t) is defined: 
Comparing the patient specific error terms to the corresponding integral terms from (9) shows that the error is small and the approximated curve does not compromise the quality of the optimisation utilising integral functions.
Thus, for a general time period [t 0 ,t] the approximation G T-approx can be used to represent the real data between measurements with no significant error as long as blood glucose levels are G T-real (t)>1, which is always true in hyperglycemia.
Integral functions also have the advantage of being insensitive to noise in the measured glucose data, effectively providing a low-pass filter in the summations involved in numerical integration.
III. RESULTS
For the long term data fitting and model verification, a random selection of 17 patients from a 201 patient data audit [6] with a period greater than one day and intervals between measured data points of three hours or less, were used. The data density of three hours was selected to ensure enough measurements to enable a good model evaluation. The entire length of stay was not always considered, as many patients only had a shorter period of data that fitted the criteria. This subset broadly represents the cross section of patients seen in the ICU, regarding medical condition, age, sex, APACHE II scores and mortality.
Two of these fits are shown in Fig. 1 and Fig. 2 . To further reduce the noise in the data and the possibility of erroneous measurements, the fitted values of p G and S I were replaced by their smoothed 3-point moving average to produce the model curve in each figure.
Patient 1090 had the lowest fitting error and standard deviation of the 17 patients considered, representing the best overall fit. Over the 1.6 days of the patient's 7-day stay, the insulin infused was constant at 1 U/hr, and the feed was constant at 0.0247 mol/(L·min). Figure 1 shows and show a change in the metabolic responses at these time periods. Over the six days, the insulin infusion and glucose feed varied significantly as well.
To measure the error in data fitting, the "chi-square" quantity is calculated for the boundaries of the range of glucose measurement error (3.5-7%) [20] . This reflects an error in the data fitting similar to the measurement error used in NRLS fitting [21] . The expected value of χ 2 is =N-M where N is the number of measurements and M=2 the number of parameters. The results are given in Table I .
The average value of ν lies between χ 2 3.5
and χ 2 7 , corresponding to a measurement error of 4.79%, which is in the range of the reported sensor measurement error. The average verification interval was 3.1 days, with the longest at 12.3 days. The average fitting error over all patients was 4.39%, with a range of 1.03-7.62%. These values are also within the experimental error.
To test the prediction capability of the model, data from three patients who had a number of measurements one hour apart, was used. The fit from the previous eight hours was used and the parameters p G , S I and G E were held constant over the next hour. The predicted value was then compared to the actual data, giving the percentage error e. This process was then repeated in moving 9 hour blocks for 15-25 Predictions per patient. The results in Table II show that one-hour predictions are on average 7-11% in error, which is also close to the measurement error. 
IV. DISCUSSION
The fitting method proves to be very effective in reducing the non-linear, non-convex optimization problem to a simple linear equation system, which is not starting point dependent. By constraining the parameter optimization to physiologically valid ranges, the resulting values for p G and S I are valid. The glucose clearance p G remained nearly constant throughout all patients, while S I showed a greater variation, which matches reported physiological behavior [22] . The average fitting error is in the range of the measurement error of the sensor and matches the expected χ 2 value. The low long-term-fit error values validate the models ability to capture the highly variable dynamics of hyperglycemic ICU patients over long periods. The prediction of the glucose values for a period of one hour ahead were within 7-11% of the actual value, further validating the p G and S I values. Note that holding these parameters constant during the prediction interval is a conservative choice, as it ignores the prior changes in value.
V. CONCLUSION
The parameter identification method shows promise for similar drug therapy models and control algorithms. The optimized model was able to capture the dynamics in the measured data to within the 7% measurement error of the sensor, and was tested for time periods up to two weeks. The model provides a prediction for one hour with an error between 7-11%, which is acceptable for control applications in a clinical setting. Due to the low computational complexity of the optimization algorithm, it is also well suited for real-time clinical control applications.
